Tiziana Life Sciences has commenced patient dosing at Yale in its Phase 2a trial of intranasal Foralumab for non‑active SPMS, ...

The Culture Media Market is undergoing a dynamic transformation, responding to the surging needs of biopharmaceutical ...

Transitioning into biotech manufacturing from industries like pharma, engineering, or food production can be strategic with ...

The combined net Q2 2025 revenue of approximately $3.0 million for prescription and non-prescription products, including license revenue, increased approximately 35% versus net Q1 2025 revenue of ...

Clinical trials are steadily becoming more complex, and the systems that support them must evolve in parallel to ensure ...

Science and technology rely on each other. Scientific progress fuels new technologies, while better technology helps science ...

ESTERO, FL / ACCESS Newswire / August 14, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug and supplement delivery ...

JERUSALEM, IL / ACCESS Newswire / August 14, 2025 / AppYea Inc. (OTCQB:APYP) today announced the appointment of Yakir Abadi as Chief Executive Officer and director and Eldar Edmond Grady as Executive ...

PM ET HOUSTON, TX / ACCESS Newswire / August 14, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel ...

Dr. Gruber provides a guide for surgeon evaluation alongside complication prevention strategies and domestic alternative options which patients should consider. TAMPA, FLORIDA / ACCESS Newswire / ...

TAMPA, FLORIDA / ACCESS Newswire / August 14, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health" or the "Company"), a leader in next-generation pharmaceutical distribution, digital ...

Clustered regularly interspaced short palindromic repeats (CRISPR)-based therapeutics are rapidly gaining traction for the management of infectious diseases. Programs targeting pathogens such as the ...